Related references
Note: Only part of the references are listed.Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
Fadi Taza et al.
CLINICAL GENITOURINARY CANCER (2023)
Randomized phase 2 trial of maintenance oral etoposide or observation following high-dose chemotherapy for relapsed metastatic germ cell tumor.
Ryan Ashkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer
Robert J. Hamilton et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2022)
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
Jonathan Shamash et al.
BRITISH JOURNAL OF CANCER (2021)
Current Management of Refractory Germ Cell Tumors
Omar Abughanimeh et al.
CURRENT ONCOLOGY REPORTS (2021)
Human chorionic gonadotropin in oncology: a matter of tight (bio)marking
Simona Ferraro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience
Mariam Imnadze Miller et al.
UROLOGY (2019)
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease
Stefanie Zschäbitz et al.
Oncotarget (2018)
The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors
Christoph Oing et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice
Simona Ferraro et al.
CLINICAL CHEMISTRY (2018)
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
Nabil Adra et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Salvage Therapy for Patients With Germ Cell Tumor
Sawsan Rashdan et al.
Journal of Oncology Practice (2016)
Canadian consensus guidelines for the management of testicular germ cell cancer
Lori Wood et al.
CUAJ-Canadian Urological Association Journal (2016)
Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection Following High-Dose Chemotherapy With Stem Cell Transplantation
Clint Cary et al.
CANCER (2015)
Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial
Anja Lorch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study
M. D. Seftel et al.
BONE MARROW TRANSPLANTATION (2011)
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
A. Lorch et al.
ANNALS OF ONCOLOGY (2010)
TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
Darren R. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
Joerg Beyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
Lawrence H. Einhorn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
GV Kondagunta et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
GM Mead et al.
BRITISH JOURNAL OF CANCER (2005)
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
JL Pico et al.
ANNALS OF ONCOLOGY (2005)
Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study
D Pectasides et al.
ANNALS OF ONCOLOGY (2004)
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis
J Beyer et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
